Page last updated on March 5, 2026
Evommune, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2026-03-05 16:07:59 EST.
Filings
10-K filed on 2026-03-05
Evommune, Inc. filed a 10-K at 2026-03-05 16:07:59 EST
Accession Number: 0001193125-26-093932
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
Item 1C. Cybersecurity. Risk management and strategy We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and clinical trial data ("Information Systems and Data"). Our Information Technology department helps identify, assess and manage our cybersecurity threats and risks. The Information Technology department identifies and assesses risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods including, for example, automated tools, conducting scans of the threat environment, evaluating our and our industry's risk profile, evaluating threats reported to us, certain internal and/or external audits, conducting threat assessments for internal and external threats, third party threat assessments, and conducting vulnerability assessments to identify vulnerabilities. Depending on the environment, we implement and maintain various technical, physical, and organizational measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity threats to our Information Systems and Data, including, for example: an incident response plan, incident detection and response measures, disaster recovery/business continuity plans, risk assessments, encryption of certain data, network security controls, segregation of certain data, access controls, physical security, asset management, tracking, and disposal, systems monitoring, employee training, penetration testing, and cybersecurity insurance. Our assessment and management of material risks from cybersecurity threats are integrated into our overall risk management program. For example: (1) cybersecurity risk is addressed as a component of our enterprise risk management program and (2) the Information Technology department works with management to evaluate material risks from cybersecurity threats against our overall business objectives. We use third-party service providers to assist us from time to time in an effort to identify, assess , and manage material risks from cybersecurity threats, including, for example, cybersecurity software providers, dark web monitoring services, and penetration testing firms. We use third-party service providers to perform a variety of functions throughout our business, such as application providers, contract research organizations, and contract manufacturing organizations. Depending on the nature of the services provided, the sensitivity of the Information Systems and Data at issue, and the identity of the provider, our vendor management process may involve different levels of assessment, including conducting audits, designed to help identify cybersecurity risks associated with a provider and impose contractual obligations related to cybersecurity on the provider. For a description of the risks from cybersecurity threats that may materially affect us and how they may do so, see our risk factors under Part 1. Item 1A. Risk Factors in this Annual Report on Form 10-K, including If our information technology systems or those of third parties with whom we work or our data, are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions, litigation, fines and penalties, disruptions of our business operations, reputational harm, loss of revenue or profits and other adverse consequences. Governance Our board of directors addresses our cybersecurity risk management as part of its general oversight function. The board of directors is responsible for overseeing our cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats. Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management including the Senior Director of Information Technology, who has over 15 years of experience leading cybersecurity programs across a variety of industries, including life sciences. The Senior Director of Information Technology is responsible for hiring appropriate personnel relevant to mitigating cybersecurity risks, helping to integrate cybersecurity risk considerations into our overall risk management strategy, and communicating key priorities to relevant personnel. The Senior Director of Information Technology is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports. Our cybersecurity incident response processes and plan are designed to escalate certain cybersecurity incidents to members of management depending on the circumstances, including senior management. Senior management works with our incident response team to help us mitigate and remediate cybersecurity incidents of which they are notified. In addition, our incident response processes and plan include reporting to the board of directors for certain cybersecurity incidents. The board of directors receives annual reports from management concerning our significant cybersecurity threats and risks and the processes we have implemented in an effort to address them. The board also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation as relevant.
Company Information
| Name | Evommune, Inc. |
| CIK | 0002044725 |
| SIC Description | Pharmaceutical Preparations |
| Ticker | EVMN - NYSE |
| Website | |
| Category | Non-accelerated filer Smaller reporting company Emerging growth company |
| Fiscal Year End | December 31 |